ADAM9 and renal cell carcinoma: The findings from the survival analysis in this study are not consistent with those in renal cell carcinoma [22] and lung adenocarcinoma [23] and may again verify the non-existence of the ADAM9/CDCP1/t-PA pathway in OSCC.